US2016114024A1PendingUtilityA1

Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium

Assignee: MORINAGA MILK INDUSTRY CO LTDPriority: Jul 12, 2013Filed: Mar 18, 2014Published: Apr 28, 2016

Est. expiryJul 12, 2033(~7 yrs left)· nominal 20-yr term from priority

Inventors:Tomohiro Tanaka Noriyuki Iwabuchi Yohei Sato Kanetada Shimizu Toshitaka Odamaki

A23K 10/18A23L 2/52A61K 35/74A61K 2035/11A23L 33/135A61K 35/747A23K 10/16A61P 31/12A61K 39/145A61P 37/04A23V 2002/00A23K 10/12A61K 2039/523A61P 31/16A23K 1/009A23L 1/3014C12R 2001/225C12N 1/205A23V 2400/165

PatentIndex Score

Cited by

References

Claims

Abstract

The Lactobacillus paracasei MCC1849 (NITE BP-01633) strain, which has a high IL-12 production-promoting action, is used as an ingredient of a drug, food or drink, or feed used for promotion of IL-12 production, immunostimulation, antivirus, or the like.

Claims

exact text as granted — not AI-modified

1 . (canceled) 
     
     
         2 . A drug which contains  Lactobacillus paracasei  MCC1849 (NITE BP-01633). 
     
     
         3 . The drug according to  claim 2 , which is for immunostimulation. 
     
     
         4 . The drug according to  claim 2 , which is for antivirus. 
     
     
         5 . The drug according to  claim 4 , wherein the virus is an influenza virus. 
     
     
         6 . A food or drink which contains  Lactobacillus paracasei  MCC1849 (NITE BP-01633). 
     
     
         7 . A feed which contains  Lactobacillus paracasei  MCC1849 (NITE BP-01633). 
     
     
         8 . An IL-12 production-promoting agent which contains  Lactobacillus paracasei  MCC1849 (NITE BP-01633). 
     
     
         9 . The IL-12 production-promoting agent according to  claim 8 , which is in the form of food or drink.

Join the waitlist — get patent alerts

Track US2016114024A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.